X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$3.28
+0.77%
Mkt Cap $298.43M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$11.67
Range $11.00 – $12.00
Implied Upside
+256.3%
Consensus $11.67 vs current $3.28
NASDAQ·Healthcare·Biotechnology
$3.28
+0.77%
Mkt Cap $298.43M
No recent rating data.
Price Target (10 analysts)
$11.67
Range $11.00 – $12.00
+256.3%
Consensus $11.67 vs current $3.28